ACB
Aristotle Capital Boston’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,342,977
| Closed | -$8.76M | – | 132 |
|
|
2023
Q3 | $8.76M | Buy |
2,342,977
+36,936
| +2% | +$138K | 0.28% | 113 |
|
|
2023
Q2 | $9.85M | Buy |
2,306,041
+51,939
| +2% | +$222K | 0.3% | 108 |
|
|
2023
Q1 | $15.4M | Buy |
2,254,102
+167,528
| +8% | +$1.15M | 0.48% | 81 |
|
|
2022
Q4 | $16.5M | Sell |
2,086,574
-54,806
| -3% | -$434K | 0.52% | 79 |
|
|
2022
Q3 | $20.6M | Sell |
2,141,380
-180,788
| -8% | -$1.74M | 0.7% | 59 |
|
|
2022
Q2 | $16.8M | Buy |
2,322,168
+129,566
| +6% | +$938K | 0.5% | 91 |
|
|
2022
Q1 | $28.3M | Buy |
2,192,602
+105,415
| +5% | +$1.36M | 0.71% | 64 |
|
|
2021
Q4 | $33.3M | Sell |
2,087,187
-68,034
| -3% | -$1.09M | 0.78% | 52 |
|
|
2021
Q3 | $34.6M | Buy |
2,155,221
+164,778
| +8% | +$2.65M | 0.81% | 50 |
|
|
2021
Q2 | $27.5M | Sell |
1,990,443
-111,244
| -5% | -$1.54M | 0.63% | 72 |
|
|
2021
Q1 | $30.7M | Buy |
2,101,687
+318,607
| +18% | +$4.65M | 0.68% | 64 |
|
|
2020
Q4 | $31M | Buy |
1,783,080
+845,806
| +90% | +$14.7M | 0.73% | 53 |
|
|
2020
Q3 | $17.2M | Buy |
937,274
+322,242
| +52% | +$5.91M | 0.5% | 82 |
|
|
2020
Q2 | $11M | Buy |
+615,032
| New | +$11M | 0.33% | 101 |
|